A follow-up study: 6-year cART-free virologic control of rhesus macaques after PD-1-based DNA vaccination against pathogenic SHIVSF162P3CN challenge

ABSTRACT An effective vaccine for combination antiretroviral therapy (cART)-free virologic control of HIV-1 by enhancing antigen-specific effector-memory CD8+ T lymphocytes could be useful in controlling the AIDS pandemic. Previously, we demonstrated that a programmed death-1 (PD-1)-based DNA vaccin...

Full description

Bibliographic Details
Published in:	Microbiology Spectrum
Main Authors:	Xiaoen He, Yik Chun Wong, Menglong Zhong, Yufei Mo, Bo Li, Lok Yan Yim, Xin Li, Wan Liu, Yanhua Du, Hui Wang, Haoji Zhang, Zhiwei Chen
Format:	Article
Language:	English
Published:	American Society for Microbiology 2023-12-01
Subjects:	long-term therapeutic efficacy SHIV HIV-1/AIDS therapeutic DNA vaccine PD-1
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.03350-23

Similar Items

Novel insights into immune checkpoints in HIV/SHIV infection: from SHIVSF162P3-infected elite controllers to therapeutic strategy
by: Yuting Sun, et al.
Published: (2025-08-01)

Viral Envelope Evolution in Simian–HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques
by: Elena E. Giorgi, et al.
Published: (2024-06-01)

Circulating Plasma Exosomal Proteins of Either SHIV-Infected Rhesus Macaque or HIV-Infected Patient Indicates a Link to Neuropathogenesis
by: Partha K. Chandra, et al.
Published: (2023-03-01)

CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques
by: Naoki Saito, et al.
Published: (2014-01-01)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
by: Rachel M. Podgorski, et al.
Published: (2023-08-01)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
by: Alice Berger, et al.
Published: (2024-03-01)

Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages
by: Gerald K. Chege, et al.
Published: (2021-03-01)

Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques.
by: Alessandra Borsetti, et al.
Published: (2014-01-01)

Naturally acquired Mycobacterium tuberculosis complex in laboratory pig-tailed macaques
by: Gregory A Engel, et al.
Published: (2012-07-01)

TLR7 Agonist GS–9620 Combined with Nicotinamide Generate Viral Reactivation in Seronegative SHIV<sub>SF162P3</sub>-Infected Rhesus Monkeys
by: Zhe Cong, et al.
Published: (2023-06-01)

Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models
by: Laury-Anne Leroy, et al.
Published: (2022-03-01)

Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
by: K. Jagannadha Sastry, et al.
Published: (2009-11-01)

A Gut Reaction to SIV and SHIV Infection: Lower Dysregulation of Mucosal T Cells during Acute Infection Is Associated with Greater Viral Suppression during cART
by: Megan A. O’Connor, et al.
Published: (2021-08-01)

Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques
by: Elise G. Viox, et al.
Published: (2025-05-01)

Susceptibility of <i>Exopalaemon carinicauda</i> to the Infection with Shrimp Hemocyte Iridescent Virus (SHIV 20141215), a Strain of Decapod Iridescent Virus 1 (DIV1)
by: Xing Chen, et al.
Published: (2019-04-01)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
by: Loyd Lee Glenn
Published: (2013-10-01)

V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
by: Tiffany M. Styles, et al.
Published: (2022-07-01)

Hindu Rashtra and Bollywood: A New Front in the Battle for Cultural Hegemony
by: Nivedita Menon
Published: (2020-11-01)

Influence of Gender on the Mechanical and Physical Properties of Hemp Shiv Fiber Cell Wall in Dioecious Hemp Plant
by: Xiaoping Li, et al.
Published: (2015-02-01)

Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
by: Chaofu Mao, et al.
Published: (2022-12-01)

Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly
by: Wannisa Khamaikawin, et al.
Published: (2015-01-01)

Virology, Epidemiology, Pathogenesis, and Control of COVID-19
by: Yuefei Jin, et al.
Published: (2020-03-01)

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge
by: Gerald K. Chege, et al.
Published: (2025-02-01)

Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine
by: Deepanwita Bose, et al.
Published: (2025-04-01)

Influence of Porous Structure of Non-Autoclaved Bio-Based Foamed Concrete on Mechanical Strength
by: Abdelrahman Mohamad, et al.
Published: (2023-09-01)

Virology, epidemiology, transmissions, diagnostic tests, prophylaxis and treatments of human Mpox: Saudi Arabia perspective
by: Almonther Abdullah Hershan
Published: (2025-02-01)

Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target
by: Valeria Guadalupe Pintor-Romero, et al.
Published: (2023-03-01)

Dual roles of methylglyoxal in cancer
by: Zongao Wang, et al.
Published: (2025-04-01)

FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis
by: Anadilton Santos da Hora, et al.

Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure
by: Luisa Mori, et al.
Published: (2020-05-01)

Ubiquitination by HUWE1 in tumorigenesis and beyond
by: Shih-Han Kao, et al.
Published: (2018-09-01)

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
by: ZHU Jianling, et al.
Published: (2024-12-01)

Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques
by: Ziyu Wen, et al.
Published: (2025-04-01)

Cell Wall Composition of Hemp Shiv Determined by Physical and Chemical Approaches
by: Maya-Sétan Diakité, et al.
Published: (2021-10-01)

Specific Substitutions in Region V2 of gp120 <i>env</i> confer SHIV Neutralisation Resistance
by: Yalcin Pisil, et al.
Published: (2020-03-01)

Intuition on virology, epidemiology, pathogenesis, and control of COVID-19
by: Gehendra Adhikari
Published: (2020-10-01)

DJ-1 Serves as a Central Regulator of Diabetes Complications
by: Feng Zhou, et al.
Published: (2025-08-01)

Factors associated with knowledge level in adult type 1 diabetic patients
by: Meriem Yazidi, et al.
Published: (2022-02-01)

A comprehensive analysis identifies and validates NPC1 as a potential biomarker for prognosis in HCC
by: Xingjun Lu, et al.
Published: (2025-08-01)

Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants
by: Zhongjie Sun, et al.
Published: (2025-01-01)